Dr Hazel Hunt

Hazel joined Argenta Discovery in May 2002 as Director of Chemistry & Operations. Prior to this, she spent over eight years at Celltech (formerly Chiroscience), most recently as Section Leader, Project Chemistry.

Hazel obtained a 1st class Honours degree at the Australian National University, and a PhD from Southampton University under the supervision of Prof R Baker. Following post-doctoral positions with Dr E J Thomas at Oxford University and Prof H W Moore at the University of California, Irvine, Hazel joined Glaxo Group Research as a Senior Medicinal Chemist. Hazel has published extensively in her maiden name (Dyke).

She has been involved in a variety of projects, including phosphodiesterase (PDE) 4 inhibitors and matrix metalloproteinase inhibitors. In Chiroscience’s collaboration with Schering Plough Inc. on the PDE4 project, Hazel had responsibility for all the chemistry undertaken. As a result of the collaboration, Schering Plough nominated a clinical candidate.

close windowprint window